Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-023093

Options or other derivatives

  • Director acquired 4,966 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Aldag Jorn Director 2019-04-01 Grant or award · Stock Option (Right to Buy) +4,966 $2.72 $13,500 4,966 D
Loading xslF345X03/doc4.xml…